Amphastar P (AMPH)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	137,545	91,386	62,116	1,403	48,939
Revenue	US$ in thousands	644,395	498,987	437,768	349,846	322,357
Net profit margin		21.34%	18.31%	14.19%	0.40%	15.18%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $137,545K ÷ $644,395K
= 21.34%

Amphastar Pharmaceuticals Inc has exhibited varying levels of net profit margin over the past five years. The net profit margin, which represents the percentage of revenue that translates into profit after all expenses have been deducted, increased from 15.18% in 2019 to 21.34% in 2023. This upward trend suggests improved efficiency in controlling costs and generating profit from sales. In 2020, the net profit margin was notably low at 0.40%, indicating challenges or exceptional expenses during that year. The subsequent years, 2021 and 2022, saw an increase in the net profit margin to 14.19% and 18.31% respectively. Overall, the positive trend in net profit margin indicates a generally positive financial performance for Amphastar Pharmaceuticals Inc in recent years.